第69回日本アレルギー学会学術大会

講演情報

Poster Session

Internal Medicine

[PE1] Poster Session 1
Adult airway diseases

[PE1-7] Baseline characteristics from phase 3, randomized controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough

David Muccino1, Masashi Kikuchi2, Alyn H Morice3, Surinder S Birring4, Lorcan McGarvey5, Peter V Dicpinigaitis6, Ian D Pavord7, Carmen La Rosa1, Christopher Assaid1, Jaclyn A Smith8 (1.Merck & Co., Inc., USA, 2.MSD K.K., Japan, 3.Hull York Medical School, UK, 4.Division of Asthma, Allergy and Lung Biology, King's College London, UK, 5.Centre for Experimental Medicine, Queen's University Belfast, UK, 6.Albert Einstein College of Medicine and Montefiore Medical Center, UK, 7.Oxford NIHR Respiratory BRC, Nuffield Department of Medicine, University of Oxford, UK, 8.Division of Infection, Immunity and Respiratory Medicine, University of Manchester, UK)

パスワードは、参加登録をいただいた皆様にメールにてご案内させていただいております。なお、第69回学術大会抄録号(69巻6・7合併号)の「参加者へのお知らせ」にも掲載しております。

パスワード